Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Hochman

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Chemmedchem|September 12, 2018
In Vivo Anticancer Activity of a Nontoxic Inert Phenolato Titanium Complex: High Efficacy on Solid Tumors Alone and Combined with Platinum DrugsNitzan Ganot, Ori Briaitbard, Asaad Gammal, et al.
Ocular Immunology and Inflammation|July 11, 2006
International Central Nervous System and Ocular Lymphoma Workshop: recommendations for the futureRobert B Nussenblatt, Chi-Chao Chan, Wyndham H Wilson, et al.
Molecules (Basel, Switzerland)|October 17, 2015
Highly Stable Tetra-Phenolato Titanium(IV) Agent Formulated into Nanoparticles Demonstrates Anti-Tumoral Activity and SelectivitySigalit Meker, Ori Braitbard, Katrin Margulis-Goshen, et al.
Virology|September 3, 2003
The leader peptide of MMTV Env precursor localizes to the nucleoli in MMTV-derived T cell lymphomas and interacts with nucleolar protein B23Hagit Hoch-Marchaim, Aryeh M Weiss, Allan Bar-Sinai, et al.
Journal of Drug Targeting|May 15, 2012
Reversing ABCB1-mediated multi-drug resistance from within cells using translocating immune conjugatesHans Wellhöner, Aryeh Weiss, Axel Schulz, et al.
Investigative Ophthalmology & Visual Science|January 27, 2005
Murine model of primary intraocular lymphomaChi-Chao Chan, Maria Fischette, DeFen Shen, et al.
Chemmedchem|March 29, 2014
Anti-proliferative activity of nano-formulated phenolato titanium(IV) complexes against cancer cellsSigalit Meker, Katrin Margulis-Goshen, Ester Weiss, et al.
Molecular Cancer Research : MCR|September 30, 2008
A Key role for cyclic AMP-responsive element binding protein in hypoxia-mediated activation of the angiogenesis factor CCN1 (CYR61) in Tumor cellsRonit Meyuhas, Eli Pikarsky, Einat Tavor, et al.
Cancer Research|August 17, 2005
Mouse mammary tumor virus Env-derived peptide associates with nucleolar targets in lymphoma, mammary carcinoma, and human breast cancerAllan Bar-Sinai, Nir Bassa, Maria Fischette, et al.
Nutrition and Cancer|June 28, 2008
Cranberry juice constituents impair lymphoma growth and augment the generation of antilymphoma antibodies in syngeneic miceNira Hochman, Yael Houri-Haddad, Jennifer Koblinski, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Chemmedchem|September 12, 2018
In Vivo Anticancer Activity of a Nontoxic Inert Phenolato Titanium Complex: High Efficacy on Solid Tumors Alone and Combined with Platinum DrugsNitzan Ganot, Ori Briaitbard, Asaad Gammal, et al.
Ocular Immunology and Inflammation|July 11, 2006
International Central Nervous System and Ocular Lymphoma Workshop: recommendations for the futureRobert B Nussenblatt, Chi-Chao Chan, Wyndham H Wilson, et al.
Molecules (Basel, Switzerland)|October 17, 2015
Highly Stable Tetra-Phenolato Titanium(IV) Agent Formulated into Nanoparticles Demonstrates Anti-Tumoral Activity and SelectivitySigalit Meker, Ori Braitbard, Katrin Margulis-Goshen, et al.
Virology|September 3, 2003
The leader peptide of MMTV Env precursor localizes to the nucleoli in MMTV-derived T cell lymphomas and interacts with nucleolar protein B23Hagit Hoch-Marchaim, Aryeh M Weiss, Allan Bar-Sinai, et al.
Journal of Drug Targeting|May 15, 2012
Reversing ABCB1-mediated multi-drug resistance from within cells using translocating immune conjugatesHans Wellhöner, Aryeh Weiss, Axel Schulz, et al.
Investigative Ophthalmology & Visual Science|January 27, 2005
Murine model of primary intraocular lymphomaChi-Chao Chan, Maria Fischette, DeFen Shen, et al.
Chemmedchem|March 29, 2014
Anti-proliferative activity of nano-formulated phenolato titanium(IV) complexes against cancer cellsSigalit Meker, Katrin Margulis-Goshen, Ester Weiss, et al.
Molecular Cancer Research : MCR|September 30, 2008
A Key role for cyclic AMP-responsive element binding protein in hypoxia-mediated activation of the angiogenesis factor CCN1 (CYR61) in Tumor cellsRonit Meyuhas, Eli Pikarsky, Einat Tavor, et al.
Cancer Research|August 17, 2005
Mouse mammary tumor virus Env-derived peptide associates with nucleolar targets in lymphoma, mammary carcinoma, and human breast cancerAllan Bar-Sinai, Nir Bassa, Maria Fischette, et al.
Nutrition and Cancer|June 28, 2008
Cranberry juice constituents impair lymphoma growth and augment the generation of antilymphoma antibodies in syngeneic miceNira Hochman, Yael Houri-Haddad, Jennifer Koblinski, et al.
Pageof 3